Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Chris Hazuka

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
corporate, Healthcare & Life Sciences, healthcare and life sciences
Office
Bay Area, San Diego, San Diego/Bay Area
Active in the record
2020 to 2025

Deal experience

Deal types
Banking & FinanceCapital Markets & IPOM&AVenture Capital & Growth
Sectors
Healthcare & Life SciencesTechnology
Jurisdictions
Cayman IslandsIrelandSingaporeUnited KingdomUnited States

Recent deals

16 announced deals in the record
Latham & Watkins Advises Chugai Pharmaceutical in US$1.085 Billion License Agreement With Rani Therapeutics 23 Oct 2025
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 1.08bn Lead corporate San Diego/Bay Area
Latham & Watkins Advises Callio Therapeutics on US$187 Million Series A Financing and Concurrent Exclusive License From Hummingbird Bioscience 5 Mar 2025
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLPLatham & Watkins LLP USD 187m Lead San Diego
Latham & Watkins Advises Coherus BioSciences in US$558.4 Million Divesture of UDENYCA Franchise to Intas Pharmaceuticals 5 Dec 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 558m intellectual property San Diego
Latham & Watkins Advises Seres Therapeutics in VOWST Asset Purchase Agreement With Nestlé Health Science 7 Aug 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP licensing and intellectual property
Latham & Watkins Advises Icosavax in US$1.1 Billion Acquisition by AstraZeneca 13 Dec 2023
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 1.10bn IP Bay Area
Latham & Watkins Advises 4D Molecular Therapeutics in License Agreement With Astellas Pharma 13 Jul 2023
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP Lead Healthcare & Life Sciences Bay Area
Latham & Watkins Advises Prometheus Biosciences in US$10.8 Billion Acquisition by Merck 18 Apr 2023
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 10.8bn intellectual property Bay Area
Latham & Watkins Advises MeiraGTx in Secured Growth Financing Agreement with Perceptive Advisors 4 Aug 2022
Banking & Finance Healthcare & Life Sciences Latham & Watkins LLP USD 100m US intellectual property Bay Area
Latham & Watkins Advises the Underwriters in Eliem Therapeutics’ Initial Public Offering 10 Aug 2021
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 80m intellectual property Bay Area
Latham & Watkins Advises the Underwriters in Absci Corporation’s IPO 22 Jul 2021
Capital Markets & IPO Technology Latham & Watkins LLP USD 200m intellectual property Bay Area
Deal alerts PRO

Get an email when Chris Hazuka is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Pro

See all 16 deals for Chris Hazuka

This page shows the 10 most recent. The paid plans open the complete history for this lawyer, with full filtering, plus:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction